Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-017109
Filing Date
2017-03-03
Accepted
2017-03-03 13:29:09
Documents
1
Period of Report
2017-03-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3132
  Complete submission text file 0001209191-17-017109.txt   4512
Mailing Address TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080
Business Address TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS INC (Issuer) CIK: 0001175505 (see all company filings)

EIN.: 260038620 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address TWO CORPORATE DRIVE C/O FIVE PRIME THERAPEUTICS, INC. SOUTH SAN FRANCISCO CA 94080
Business Address
Borges Luis (Reporting) CIK: 0001684015 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36070 | Film No.: 17662580